Abstract

Methylphenidate Hydrochloride 10-mg Capsules

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2014 - Volume 18, Number 6

Page(s): 501

Download in electronic PDF format for $75

Abstract

A formulation for preparing Methylphenidate Hydrochloride 10-mg Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2014 Pg. 501	Methylphenidate Hydrochloride 10-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 244	Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 21-22	Methylphenidate in the Treatment of Attention Deficit Disorders Author(s): Tenreiro Kim
Mar/Apr 1997 Pg. 87-89	Attention Deficit Hyperactivity Disorder Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 496	Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 249	Methylphenidate 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 516-526	Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
May/Jun 2022 Pg. 233	Azstarys in Ora-Blend Single Dose Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 133	Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 512	Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 389-393	Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Author(s): Alexander Kenneth S, Thyangarajapuram N
May/Jun 2016 Pg. 231	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 135	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 246	Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 308-315	Transdermals: The Skin as Part of a Drug Delivery System Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 235	Naltrexone Hydrochloride 50-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 238-241	Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
May/Jun 2020 Pg. 252-262	Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4 Author(s): Polonini Hudson, Loures da Silva Sharlene, Neves Cunha Carolina, de Oliveira Ferreira Anderson, Anagnostou Korina, Dijkers Eli